A
Andrea Zambruni
Researcher at University of Bologna
Publications - 19
Citations - 696
Andrea Zambruni is an academic researcher from University of Bologna. The author has contributed to research in topics: QT interval & Cirrhosis. The author has an hindex of 10, co-authored 19 publications receiving 640 citations.
Papers
More filters
Journal ArticleDOI
Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience
Federica Mirici-Cappa,Annagiulia Gramenzi,V. Santi,Andrea Zambruni,Antonio Di Micoli,Marta Frigerio,Francesca Maraldi,Maria Anna Di Nolfo,Paolo Poggio,Luisa Benvegnù,Gianludovico Rapaccini,Fabio Farinati,Marco Zoli,Franco Borzio,Edoardo G. Giannini,Eugenio Caturelli,Mauro Bernardi,Franco Trevisani +17 more
TL;DR: The overall applicability of radical or effective HCC treatments was unaffected by old age, however, treatment distribution differed, elderly individuals being more frequently treated with percutaneous procedures and less frequently with resection or TACE.
Journal ArticleDOI
Cardiac electrophysiological abnormalities in patients with cirrhosis.
TL;DR: This review will deal with the three abnormalities of cardiac electrophysiology most frequently encountered in cirrhosis: (1) chronotropic incompetence; (2) electromechanical uncoupling, and (3) electrocardiographic QT interval prolongation.
Journal ArticleDOI
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt.
Franco Trevisani,Manuela Merli,Francesco Savelli,Valentina Valeriano,Andrea Zambruni,Oliviero Riggio,Paolo Caraceni,Marco Domenicali,Mauro Bernardi +8 more
TL;DR: The results suggest that the porto-systemic shunting is responsible for the altered ventricular repolarisation possibly through a dumping into the systemic circulation of splanchnic-derived cardioactive substances.
Journal ArticleDOI
Effect of chronic β-blockade on QT interval in patients with liver cirrhosis
Andrea Zambruni,Franco Trevisani,Antonio Di Micoli,Francesco Savelli,Annalisa Berzigotti,Eleonora Bracci,Paolo Caraceni,Marco Domenicali,Palmiro Felline,Marco Zoli,Mauro Bernardi +10 more
TL;DR: Chronic beta-blockade shortens the QT interval only in patients with prolonged baseline values, and this is likely due to a direct cardiac effect.
Journal ArticleDOI
Cannabinoid Type 1 Receptor Antagonism Delays Ascites Formation in Rats With Cirrhosis
Marco Domenicali,Paolo Caraceni,Ferdinando Giannone,Anna Maria Pertosa,A. Principe,Andrea Zambruni,Franco Trevisani,T. Croci,Mauro Bernardi +8 more
TL;DR: Rimonabant improves sodium balance and delays decompensation in preascitic cirrhosis though an improvement in systemic and renal hemodynamics, although it cannot be excluded that the antifibrotic effect of the drug may play a role.